lilly tirzepatide news - Search News

Lilly weight-loss drug copycats dealt blow

Hosted on MSN · 22h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

Lilly’s Tirzepatide No Longer on FDA Drug Shortage List

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes and weight loss drugs are gaining market share as manufacturing continues to expand,

The Washington Post · 18h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

Obesity Drug Shortage Ends for Lilly, Continues for Novo as Industry Bolsters Manufacturing

Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...

1h

England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access

NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to ...

1d

Eli Lilly & Co: Resolution of Tirzepatide Supply Issue Bolsters Buy Rating

Deutsche Bank analyst James Shin maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of ...

1don MSN

Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...

2h

NHS proposes phased launch for Eli Lilly’s Mounjaro

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results